Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 9/20 | 0.68 |
| ▸ | ADRB1 | P08588 | 5/20 | 0.56 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.53 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.53 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | CTPS1 | P17812 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6621610 | 0.88 | ADRB3 (0.70) | ADRB3ADRB1ADRB2CYP2D6SLC6A4 | |
| SCHEMBL15994158 | 0.88 | ADRB3 (0.70) | ADRB3ADRB1ADRB2CYP2D6SLC6A4 | |
| SCHEMBL21952232 | 0.87 | ADRB3 (0.69) | ADRB3ADRB1ADRB2CYP2D6SLC6A4 | |
| SCHEMBL16609338 | 0.87 | ADRB3 (0.69) | ADRB3ADRB1ADRB2CYP2D6SLC6A4 | |
| SCHEMBL25159572 | 0.86 | ADRB3 (0.68) | ADRB3ADRB1ADRB2CYP2D6SLC6A4 | |
| SCHEMBL28986806 | 0.86 | ADRB3 (0.68) | ADRB3ADRB1ADRB2CYP2D6SLC6A4 | |
| SCHEMBL28986807 | 0.86 | ADRB3 (0.68) | ADRB3ADRB1ADRB2CYP2D6SLC6A4 | |
| SCHEMBL16609246 | 0.84 | ADRB3 (0.66) | ADRB3ADRB1ADRB2CYP2D6SLC6A4 | |
| SCHEMBL17209111 | 0.82 | ADRB3 (0.62) | ADRB3ADRB1ADRB2CYP2D6SLC6A4 | |
| SCHEMBL16609237 | 0.82 | ADRB3 (0.62) | ADRB3ADRB1ADRB2CYP2D6SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250051295-A1 | PROCESS FOR THE PREPARATION OF MIRABEGRON FREE FROM GENOTOXIC IMPURITIES | ZYDUS LIFESCIENCES LIMITED (IN) | 2025-02-13 | — | — | US | claimed |
| US-20250051295-A1 | PROCESS FOR THE PREPARATION OF MIRABEGRON FREE FROM GENOTOXIC IMPURITIES | ZYDUS LIFESCIENCES LIMITED (IN) | 2025-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051295-A1 | PROCESS FOR THE PREPARATION OF MIRABEGRON FREE FROM GENOTOXIC IMPURITIES | UGT1A6, UGT1A1, UGT1A3 | ADRB3 4/4885ADRB1 10/4885ADRB2 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.